Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Once cautious, OpenAI, Grok, and others will now dive into giving unverified medical advice with virtually no disclaimers.

Although patients and the general public were identified as the primary audience, the researchers noted that AI-generated podcasts could serve as a cost-effective, scalable way for healthcare ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Daniel Nadler started OpenEvidence to help physicians sort through a deluge of medical research. Now, he’s raised $210 ...

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Microsoft's new model-agnostic MAI Diagnostic Orchestrator (MAI-DxO) achieved 85.5 percent diagnostic accuracy—outperforming ...

Google DeepMind researchers believe that by building for India's linguistic, economic, and cultural complexity, their work ...